Compound heterozygous mutations of TYMP as underlying causes of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Suh,Bum  Chun; Jeong,Ha-Neul; Yoon,Byung  Suk; Park,Ji  Hoon; Kim,Hye  Jin; Park,Sun  Wha; Hwang,Jung  Hee; Choi,Byung-Ok; Chung,Ki  Wha

doi:10.3892/mmr.2013.1479

Compound heterozygous mutations of TYMP as underlying causes of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Authors:
- Bum Chun Suh
- Ha-Neul Jeong
- Byung Suk Yoon
- Ji Hoon Park
- Hye Jin Kim
- Sun Wha Park
- Jung Hee Hwang
- Byung-Ok Choi
- Ki Wha Chung
View Affiliations

Affiliations: Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, Department of Biological Science, Kongju National University, Gongju, Republic of Korea, DNA Analysis Division, National Forensic Service, Seoul, Republic of Korea, Department of Neurology, Ewha Womans University School of Medicine, Seoul, Republic of Korea
Published online on: May 16, 2013 https://doi.org/10.3892/mmr.2013.1479
Pages: 17-22

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), an autosomal recessive multiorgan disease, frequently associated with mutations in the thymidine phosphorylase (TYMP) gene. TYMP encodes thymidine phosphorylase (TP), which has an essential role in the nucleotide salvage pathway for mitochondrial DNA (mtDNA) replication. This study reports an MNGIE patient with novel compound heterozygous missense mutations (Thr151Pro and Leu270Pro) in TYMP. Each mutation was inherited from one parent. Neither mutation was found in the controls and the mutation sites were well conserved between different species. Neither large deletion nor causative point mutations were found in the mtDNA. The patient presented with MNGIE symptoms, including gastrointestinal discomfort, external ophthalmoplegia, pigmentary retinopathy and demyelinating type diffuse sensory motor polyneuropathy. The patient demonstrated an early-onset but mild phenotype, with 9.6% TP activity; therefore, patients with these compound heterozygous mutations may exhibit a mild phenotype with a variable onset age according to TP activity level.

View Figures

View References

1	Spelbrink JN, Li FY, Tiranti V, et al: Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet. 28:223–231. 2001. View Article : Google Scholar : PubMed/NCBI
2	Hirano M, Nishigaki Y and Martí R: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist. 10:8–17. 2004. View Article : Google Scholar : PubMed/NCBI
3	Spinazzola A and Zeviani M: Disorders of nuclear-mitochondrial intergenomic signaling. Gene. 354:162–168. 2005. View Article : Google Scholar : PubMed/NCBI
4	Suomalainen A and Isohanni P: Mitochondrial DNA depletion syndromes - many genes, common mechanisms. Neuromuscul Disord. 20:429–437. 2010. View Article : Google Scholar : PubMed/NCBI
5	Nishino I, Spinazzola A and Hirano M: Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 283:689–692. 1999. View Article : Google Scholar : PubMed/NCBI
6	Vissing J, Ravn K, Danielsen ER, et al: Multiple mtDNA deletions with features of MNGIE. Neurology. 59:926–929. 2002. View Article : Google Scholar : PubMed/NCBI
7	Van Goethem G, Schwartz M, Löfgren A, et al: Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet. 11:547–549. 2003.
8	Shaibani A, Shchelochkov OA, Zhang S, et al: Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol. 66:1028–1032. 2009. View Article : Google Scholar : PubMed/NCBI
9	Kollberg G, Darin N, Benan K, et al: A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion. Neuromuscul Disord. 19:147–150. 2009. View Article : Google Scholar : PubMed/NCBI
10	Naviaux RK and Nguyen KV: POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol. 55:706–712. 2004.
11	Tyynismaa H, Ylikallio E, Patel M, Molnar MJ, Haller RG and Suomalainen A: A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. Am J Hum Genet. 85:290–295. 2009. View Article : Google Scholar
12	Gamez J, Ferreiro C, Accarino ML, et al: Phenotypic variability in a Spanish family with MNGIE. Neurology. 59:455–457. 2002. View Article : Google Scholar : PubMed/NCBI
13	Szigeti K, Wong LJ, Perng CL, et al: MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation. J Med Genet. 41:125–129. 2004. View Article : Google Scholar : PubMed/NCBI
14	Hirano M, Lagier-Tourenne C, Valentino ML, Martí R and Nishigaki Y: Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene. 354:152–156. 2005. View Article : Google Scholar : PubMed/NCBI
15	Martí R, Verschuuren JJ, Buchman A, et al: Late-onset MNGIE due to partial loss of thymidine phosphorylase activity. Ann Neurol. 58:649–652. 2005.PubMed/NCBI
16	Massa R, Tessa A, Margollicci M, et al: Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity. Neuromuscul Disord. 19:837–840. 2009. View Article : Google Scholar : PubMed/NCBI
17	Libernini L, Lupis C, Mastrangelo M, et al: Mitochondrial neurogastrointestinal encephalomyopathy: novel pathogenic mutations in thymidine phosphorylase gene in two Italian brothers. Neuropediatrics. 43:201–208. 2012. View Article : Google Scholar
18	Ishikawa F, Miyazono K, Hellman U, et al: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 338:557–562. 1989. View Article : Google Scholar : PubMed/NCBI
19	Bakker JA, Schlesser P, Smeets HJ, Francois B and Bierau J: Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome. J Inherit Metab Dis. 2010:Feb 12–2010.(Epub ahead of print).
20	Haraguchi M, Tsujimoto H, Fukushima M, et al: Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice. Mol Cell Biol. 22:5212–5222. 2002. View Article : Google Scholar : PubMed/NCBI
21	López LC, Akman HO, García-Cazorla A, et al: Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet. 18:714–722. 2009.PubMed/NCBI
22	Tamura K, Peterson D, Peterson N, Stecher G, Nei M and Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 28:2731–2739. 2011. View Article : Google Scholar
23	Ingman M and Gyllensten U: mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res. 34:D749–D751. 2006.PubMed/NCBI
24	Tanaka M, Takeyasu T, Fuku N, Li-Jun G and Kurata M: Mitochondrial genome single nucleotide polymorphisms and their phenotypes in the Japanese. Ann NY Acad Sci. 1011:7–20. 2004. View Article : Google Scholar : PubMed/NCBI
25	Hagiwara K, Stenman G, Honda H, et al: Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol Cell Biol. 11:2125–2132. 1991.PubMed/NCBI
26	Asai K, Nakanishi K, Isobe I, et al: Neurotrophic action of gliostatin on cortical neurons. Identity of gliostatin and platelet-derived endothelial cell growth factor. J Biol Chem. 267:20311–20316. 1992.PubMed/NCBI